1-7 of 7
gemtuzumab
Close
Sort by
Journal Articles

Single-agent and combination biologics in acute myeloid leukemia

Guillaume Richard-Carpentier, Courtney D. DiNardo
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 548–556.
https://doi.org/10.1182/hematology.2019000059
Published: 2019
Journal Articles

The role of targeted therapy in the management of patients with AML

Alexander E. Perl
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 54–65.
https://doi.org/10.1182/asheducation-2017.1.54
Published: 2017
Journal Articles

MRD in AML: does it already guide therapy decision-making?

Gert Ossenkoppele, Gerrit Jan Schuurhuis
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 356–365.
https://doi.org/10.1182/asheducation-2016.1.356
Published: 2016
Journal Articles

Intermediate-risk acute myeloid leukemia therapy: current and future

Konstanze Döhner, Peter Paschka
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 34–43.
https://doi.org/10.1182/asheducation.V2014.1.34.3882398
Published: 2014
Journal Articles

Novel Antibody-Based Therapies For Acute Lymphoblastic Leukemia

Dieter Hoelzer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 243–249.
https://doi.org/10.1182/asheducation-2011.1.243
Published: 2011
Journal Articles

New Trends in the Standard of Care for Initial Therapy of Acute Myeloid Leukemia

Hugo F. Fernandez
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 56–61.
https://doi.org/10.1182/asheducation-2010.1.56
Published: 2010
Journal Articles

New Strategies for the Treatment of Acute Myeloid Leukemia Including Antibodies and Other Novel Agents

Martin S. Tallman
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 143–150.
https://doi.org/10.1182/asheducation-2005.1.143
Published: 2005